These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis. Van Pel A, Boon T. Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4718-22. PubMed ID: 6981814 [Abstract] [Full Text] [Related]
7. Tumour cell variants with increased immunogenicity obtained by mutagen treatment. Boon T, Maryanski J. Cancer Surv; 1985 Aug; 4(1):135-48. PubMed ID: 3879855 [Abstract] [Full Text] [Related]
8. Ability of spleen cells from tumor bearing mice to transfer immunologic memory. Plavsić B, Jurin M, Ugarković B. Acta Radiol Oncol; 1983 Aug; 22(5):385-8. PubMed ID: 6320597 [Abstract] [Full Text] [Related]
9. Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Siesjö P, Visse E, Lindvall M, Salford L, Sjögren HO. Cancer Immunol Immunother; 1993 Jul; 37(1):67-74. PubMed ID: 8513454 [Abstract] [Full Text] [Related]
10. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma. Elliott BE, Carlow DA, Ivimey L, Arnold M, Hampton N, Bosman P. Cancer Res; 1987 Sep 15; 47(18):4915-23. PubMed ID: 2441856 [Abstract] [Full Text] [Related]
12. Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumor. Georlette M, Boon T. Eur J Cancer Clin Oncol; 1981 Oct 15; 17(10):1083-7. PubMed ID: 7200017 [No Abstract] [Full Text] [Related]
15. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation. Peppoloni S, Herberman RB, Gorelik E. Cancer Res; 1985 Jun 15; 45(6):2560-6. PubMed ID: 2580624 [Abstract] [Full Text] [Related]
16. Syngeneic immune response to rat tracheal epithelial cells transformed in vitro by N-methyl-N-nitro-N-nitrosoguanidine. Braslawsky GR, Steele V, Kennel SJ, Nettesheim P. Br J Cancer; 1981 Aug 15; 44(2):247-57. PubMed ID: 7272190 [Abstract] [Full Text] [Related]
17. Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma. Zbar B, Sukumar S, Tanio Y, Terata N, Hovis J. Cancer Res; 1984 Nov 15; 44(11):5079-85. PubMed ID: 6488168 [Abstract] [Full Text] [Related]
18. Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815. Marchand M, Caspar P, Boon T. Eur J Cancer Clin Oncol; 1983 Nov 15; 19(11):1529-37. PubMed ID: 6196202 [Abstract] [Full Text] [Related]
19. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine. Gorelik E, Peppoloni S, Overton R, Herberman RB. Cancer Res; 1985 Nov 15; 45(11 Pt 1):5341-7. PubMed ID: 2413992 [Abstract] [Full Text] [Related]
20. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens. Altevogt P, von Hoegen P, Leidig S, Schirrmacher V. Cancer Res; 1985 Sep 15; 45(9):4270-7. PubMed ID: 4028013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]